Pinnacle Wealth Planning Services Inc. lessened its position in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 31.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,610 shares of the financial services provider’s stock after selling 1,215 shares during the quarter. Pinnacle Wealth Planning Services Inc.’s holdings in Aflac were worth $270,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new position in Aflac during the 4th quarter valued at approximately $163,409,000. Vision Financial Markets LLC purchased a new position in shares of Aflac in the 4th quarter worth approximately $559,000. Proficio Capital Partners LLC purchased a new position in shares of Aflac in the 4th quarter worth approximately $192,000. Assetmark Inc. boosted its holdings in shares of Aflac by 2.0% in the 4th quarter. Assetmark Inc. now owns 1,616,772 shares of the financial services provider’s stock worth $167,239,000 after purchasing an additional 32,220 shares during the period. Finally, Commerzbank Aktiengesellschaft FI boosted its holdings in shares of Aflac by 332.1% in the 4th quarter. Commerzbank Aktiengesellschaft FI now owns 12,622 shares of the financial services provider’s stock worth $1,300,000 after purchasing an additional 9,701 shares during the period. Hedge funds and other institutional investors own 67.44% of the company’s stock.
Aflac Trading Up 0.5 %
Shares of NYSE AFL opened at $108.48 on Friday. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The business has a fifty day simple moving average of $105.08 and a two-hundred day simple moving average of $107.70. The firm has a market cap of $59.29 billion, a PE ratio of 11.30, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a twelve month low of $79.31 and a twelve month high of $115.50.
Analyst Ratings Changes
AFL has been the subject of a number of recent research reports. Barclays dropped their target price on Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, February 7th. Keefe, Bruyette & Woods dropped their target price on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a report on Wednesday, February 12th. Evercore ISI dropped their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. JPMorgan Chase & Co. lifted their target price on Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a report on Tuesday, January 7th. Finally, Morgan Stanley lifted their target price on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $103.36.
View Our Latest Report on Aflac
Insider Transactions at Aflac
In other news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.90% of the company’s stock.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
- Five stocks we like better than Aflac
- Energy and Oil Stocks Explained
- Is Myers Industries Poised for a Breakout?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Stock Dividend Cuts Happen Are You Ready?
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.